Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNA2 | P51530 | 1/20 | 0.56 |
| ▸ | CASP6 | P55212 | 1/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CSNK2A1 | P68400 | 5/20 | 0.43 |
| ▸ | CSNK2A2 | P19784 | 4/20 | 0.43 |
| ▸ | CSNK2B | P67870 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DTYMK | P23919 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2980616 | 0.84 | CASP6 (0.56) | DNA2CASP6CTDSP1CYP1A2HSD17B10 | |
| SCHEMBL7552991 | 0.78 | CASP6 (0.50) | DNA2CASP6CTDSP1CYP1A2HSD17B10 | |
| SCHEMBL7515189 | 0.77 | CYP1A2 (0.49) | DNA2CASP6CTDSP1CYP1A2HSD17B10 | |
| SCHEMBL3613665 | 0.74 | BRPF1 (0.46) | DNA2CASP6CTDSP1CYP1A2HSD17B10 | |
| SCHEMBL18509691 | 0.74 | FBP1 (0.47) | TSHRHPGD | |
| SCHEMBL4334739 | 0.72 | DNA2 (1.00) | DNA2CASP6CTDSP1CYP1A2HSD17B10 | |
| SCHEMBL6537443 | 0.72 | CASP6 (0.44) | DNA2CASP6CTDSP1HSD17B10TSHR | |
| SCHEMBL6537881 | 0.71 | CASP6 (0.45) | DNA2CASP6CTDSP1HSD17B10TSHR | |
| SCHEMBL18000254 | 0.71 | PTPRA (0.49) | HSD17B10TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL18000189 | 0.71 | PTPRA (0.49) | HSD17B10TSHRKDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020193591-A1 | Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof | DAIICHI PHARMACEUTICAL CO., LTD. | 2002-12-19 | — | — | US | disclosed |
| EP-1167344-A1 | PROCESS FOR PRODUCING 5-AMINO-8- ALKYLQUINOLO NECARBOXYLIC ACID DERIVATIVES AND INTERMEDIATES IN THE PRODUCTION THEREOF | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193591-A1 | Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof | SQOR, XDH, SPOUT1 | DNA2 1658/4885CASP6 535/4885CTDSP1 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.